Ocean Biomedical (OCEAW) Stock Price, News & Analysis

Company Overview

Ocean Biomedical is a biotechnology company focused on advancing medical discoveries into potential treatments. Its research programs have targeted cancer, infectious diseases and fibrotic conditions, including lung and brain cancers, malaria and pulmonary fibrosis.

The company has pursued development of these programs through research collaborations and licensing arrangements with academic and medical institutions. Its work is in the drug-development stage rather than the sale of marketed therapies.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 122,900 shs
• Average Volume: 42,967 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:OCEAW
• CIK: 1869974
• Web: www.oceanbiomedical.com
• Phone: 401-444-7375
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A